Fumagillin (1) was originally isolated from Aspergillus fumigatus^as an antiparasitic, 2) and belongs to the sesquiterpene family of compounds. In later biological studies, fumagillin and its analogs were reported as highly potent angiogenesis inhibitors, which inhibit endothelial cell proliferation in vitro and tumor-induced angiogenesis in vivo?~5) Methionine aminopeptidase-2 (MetAP-2), the specific enzyme was recently discovered to be the molecular target of fumagillin.6'7)
The binding mode oi fumagillin to the enzyme was further revealed by X-ray crystallographic analysis.8) Furthermore, a semisynthetic analog of fumagillin, TNP-470 (AGM-1470), is currently in phase II clinical trials for the treatment of patients with a variety of cancers, including Kaposi's sarcoma, breast, cervical, lung and renal cancer.9'"13) In order to provide pure material for biological studies in our anti-cancer program, as well as to search for somenew analogs, an isolation project of fumagillin and related compounds was launched.
In the process of large-scale preparation of fumagillin, Sch 528657 (2), a novel metabolite closely related to fumagillin was discovered from Aspergillusfumigatus as shown in Fig.  1 . Herewith, we wish to report on the isolation, structure elucidation and biological activity of 2.
The crude ethyl acetate extract from 100 liters fermentation broth was chromatographed on silica gel column eluting with hexane and ethyl acetate (1 : 1) t o obtain the enriched mixture of 1 containing a small amount of 2 (-2% order to elucidate the structure of 2. Three fragments A, B and C were further established based on HMQC-TOCSY data as shown in Fig. 2 . The assignments of protons and carbons were completed by the analysis of HMBC data as depicted in Fig. 3 . The relative stereochemistry of 2 was determined by NOESYexperiments, which revealed its similarity to fumagillin as shown in Fig. 4 . Compound2 exhibited fairly potent antitumor activity against melanoma cells (SKMEL-5cells) in the soft agar assay with an IC50=250 nM. However, compound 1 elicited better potency with an 1050=8nM. This result of a >31-fold potency decrease strongly suggested that the 
